Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Excursion to Different Universes: the Top Sci-fi Motion pictures Ever - 2The Electric Bicycle Americans Can Confide in 2024
- 3Opening Potential: Self-awareness and Long lasting Learning
- 4Manual for Vegetarian Protein Powder
- 55 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Behind every perfect holiday memory is a mom on the brink
- A Couple of Reasonable Guitars for 2024
- Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- Overhaul Your Rest: Tips for a Peaceful Evening
- SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- Step by step instructions to Show Children the Significance of Appropriate Handshaking
- Language Learning Stages: Which One Gets Your Vote?
- Vote in favor of your Number one Kind of Gems
